Former HHS Head Says Delay In Becerra Confirmation Also Blocks Lower Appointments

Hold-up in US Senate approval of Becerra causing hardships at CMS, CDC, former HHS Secretary Kathleen Sebelius says

The former Obama HHS Secretary says not having health leadership in place is exacerbating the COVID-19 crisis and even increasing deaths.

HHS Building_1200
Confirmation of an HHS Secretary to oversee resolution of the COVID-19 crisis is paramount, former HHS chief says

Senate Republicans seem to be slow-walking the nomination of California Attorney General Xavier Becerra as Secretary of the Department of Health and Human Services over concerns his politics lean too far to the left. But at the height of a pandemic, not having a confirmed Health and Human Services Secretary already confirmed also means no one can take the reins at the Centers for Medicare and Medicaid Services, the Centers for Disease Control and Prevention, or other COVID-19 prevention agencies, said former HHS leader Kathleen Sebelius.

“Clearly, we are in the midst of a distorting pandemic, which not only causes a huge health crisis, but also an economic crisis,” Sebelius said during an Accountable.US webinar on 12 February. Accountable

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation

Debate On FDA User Fee Reauthorization Begins To Take Shape

 
• By 

A battle may be forming over the 2027 FDA user fee reauthorizations. At a conference Friday, Democratic Rep. Jake Auchincloss supports them for their effectiveness, while Deputy FDA Commissioner Grace Graham echoed criticisms from HHS Sec. Kennedy, among others, in calling for reform to ensure public trust.

Health Secretary Defends Spending Cuts During Senate Hearing On HHS Budget

 
• By 

Health and Human Services Secretary Robert F. Kennedy Jr. emphasized administrative cost reductions and defended budget decisions during a Senate hearing on HHS funding. Some senators, however, expressed concerns over the impacts spending cuts had on essential health programs.

Tariffs Threaten Medtech Innovation And US Position As World Leader, Whitaker Tells Lawmakers

 

During his testimony before US senators on the impact of tariffs on critical supply chains, AdvaMed’s Scott Whitaker said the Trump tariffs could jeopardize America’s preeminence in medtech. Other industry experts echoed similar concerns.